Avidia

Avidia expands senior management team

Published in Biotech Law Weekly, July 28th, 2006

Avidia, Inc., a privately-held biopharmaceutical company focused on discovering and developing a new class of human therapeutic proteins, announced the appointment of Paulette A. Dillon as senior vice president and chief business officer and Charles Sholtz, PhD, JD, as vice president of intellectual property and legal affairs.

"Avidia's therapeutic discovery programs have advanced to a stage in which partnerships and licensing are expected to add to the sustained value growth of the company. Paulette has the right background and experience to help us capitalize on the external interest in our programs," said Peter Van Vlasselaer, PhD, Avidia's chief executive officer....

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Law Weekly

Source: Biotech Law Weekly (2006-07-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry